Protective Effects of Cyclosporin H Against Sepsis-Induced Acute Kidney Injury via Modulation of Fpr1 Signaling and Inhibiting Pyroptosis.

IF 2.4 Q2 UROLOGY & NEPHROLOGY
Research and Reports in Urology Pub Date : 2026-03-07 eCollection Date: 2026-01-01 DOI:10.2147/RRU.S578231
Hangwei Feng, Linqian Jiang, Cuilian Weng
{"title":"Protective Effects of Cyclosporin H Against Sepsis-Induced Acute Kidney Injury via Modulation of Fpr1 Signaling and Inhibiting Pyroptosis.","authors":"Hangwei Feng, Linqian Jiang, Cuilian Weng","doi":"10.2147/RRU.S578231","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to identify potential targets and mechanisms of sepsis-associated acute kidney injury (SA-AKI) using transcriptomic analysis.</p><p><strong>Methods: </strong>First, SA-AKI model was established by intraperitoneal LPS injection. Second, transcriptome sequencing was performed to analyze key targets and mechanisms in SA-AKI. Finally, we investigated the therapeutic effects of the Fpr1 inhibitor Cyclosporin H on the SA-AKI model.</p><p><strong>Results: </strong>H&E staining revealed intact renal structure in the control group, while the SA-AKI group showed structural damage, glomerular atrophy, and inflammatory cell infiltration. Serum levels of blood urea nitrogen and creatinine were significantly elevated in the SA-AKI group compared to controls (P<0.001). ELISA detection showed significantly higher TNF-α and IL-1β levels in both serum and kidney tissues of the SA-AKI group (P<0.001). Transcriptome analysis identified 209 differentially expressed genes between SA-AKI and control groups, with 194 upregulated and 15 downregulated genes. GO and KEGG analyses indicated that these genes primarily participated in leukocyte migration, phagocytosis, leukocyte chemotaxis, chemokine signaling pathways, and viral protein-cytokine interactions. qPCR confirmed significantly higher expression of Ubd, Fpr1, Fpr2, C3, B2m, and Itgam in the SA-AKI group (P<0.01). Following Cyclosporin H intervention, renal tissue damage was significantly ameliorated, with reduced renal function indicators and inflammatory markers. Additionally, TUNEL staining and transmission electron microscopy showed decreased TUNEL-positive cells, reduced mitochondrial damage, and fewer pyroptotic features after Cyclosporin H treatment. Western blot analysis demonstrated significantly decreased levels of ASC, Caspase-1, NLRP3, and IL-1β proteins after Cyclosporin H intervention (P<0.001).</p><p><strong>Conclusion: </strong>Fpr1 may serve as a key mediator in the SA-AKI. Cyclosporin H may improve sepsis-induced kidney injury and inflammation by inhibiting pyroptosis, providing a potential early therapeutic intervention.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"18 ","pages":"578231"},"PeriodicalIF":2.4000,"publicationDate":"2026-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12978002/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research and Reports in Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/RRU.S578231","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study aimed to identify potential targets and mechanisms of sepsis-associated acute kidney injury (SA-AKI) using transcriptomic analysis.

Methods: First, SA-AKI model was established by intraperitoneal LPS injection. Second, transcriptome sequencing was performed to analyze key targets and mechanisms in SA-AKI. Finally, we investigated the therapeutic effects of the Fpr1 inhibitor Cyclosporin H on the SA-AKI model.

Results: H&E staining revealed intact renal structure in the control group, while the SA-AKI group showed structural damage, glomerular atrophy, and inflammatory cell infiltration. Serum levels of blood urea nitrogen and creatinine were significantly elevated in the SA-AKI group compared to controls (P<0.001). ELISA detection showed significantly higher TNF-α and IL-1β levels in both serum and kidney tissues of the SA-AKI group (P<0.001). Transcriptome analysis identified 209 differentially expressed genes between SA-AKI and control groups, with 194 upregulated and 15 downregulated genes. GO and KEGG analyses indicated that these genes primarily participated in leukocyte migration, phagocytosis, leukocyte chemotaxis, chemokine signaling pathways, and viral protein-cytokine interactions. qPCR confirmed significantly higher expression of Ubd, Fpr1, Fpr2, C3, B2m, and Itgam in the SA-AKI group (P<0.01). Following Cyclosporin H intervention, renal tissue damage was significantly ameliorated, with reduced renal function indicators and inflammatory markers. Additionally, TUNEL staining and transmission electron microscopy showed decreased TUNEL-positive cells, reduced mitochondrial damage, and fewer pyroptotic features after Cyclosporin H treatment. Western blot analysis demonstrated significantly decreased levels of ASC, Caspase-1, NLRP3, and IL-1β proteins after Cyclosporin H intervention (P<0.001).

Conclusion: Fpr1 may serve as a key mediator in the SA-AKI. Cyclosporin H may improve sepsis-induced kidney injury and inflammation by inhibiting pyroptosis, providing a potential early therapeutic intervention.

环孢素H通过调节Fpr1信号和抑制焦亡对脓毒症诱导的急性肾损伤的保护作用。
目的:本研究旨在通过转录组学分析确定脓毒症相关急性肾损伤(SA-AKI)的潜在靶点和机制。方法:首先,通过腹腔注射LPS建立SA-AKI模型。其次,进行转录组测序以分析SA-AKI的关键靶点和机制。最后,我们研究了Fpr1抑制剂环孢素H对SA-AKI模型的治疗作用。结果:H&E染色显示对照组肾结构完整,SA-AKI组肾结构损伤,肾小球萎缩,炎症细胞浸润。与对照组相比,SA-AKI组血清尿素氮和肌酐水平显著升高(结论:Fpr1可能是SA-AKI的关键介质。环孢素H可能通过抑制焦亡来改善败血症引起的肾损伤和炎症,提供了一种潜在的早期治疗干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Research and Reports in Urology
Research and Reports in Urology UROLOGY & NEPHROLOGY-
CiteScore
3.40
自引率
0.00%
发文量
60
审稿时长
16 weeks
期刊介绍: Research and Reports in Urology is an international, peer-reviewed, open access, online journal. Publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease Investigation and treatment of urological disease Pharmacology of drugs used for the treatment of urological disease Although the main focus of the journal is to publish research and clinical results in humans; preclinical, animal and in vitro studies will be published where they will shed light on disease processes and potential new therapies. Issues of patient safety and quality of care will also be considered.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书